Company News

Connect 2 Cleanrooms appoints new MD and CEO Michael Wright will succeed founding MD Joe Govier who has moved to the CEO role Ex-FDA Commissioner joins Pfizer Scott Gottlieb will also be a part of the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board Newcomer Quell Therapeutics appoints Iain McGill as CEO The company was founded in March 2019, in a partnership between prominent experts from King's College London, University College London, and Hannover Medical School Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics In his new role Ahiska will spearhead the commercialisation of the group’s EpiSwitch technology platform Domain Therapeutics adds Sylvie Ryckebusch to Board Ryckebusch joins Domain from Merck Serono Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach Caddy-Leach will take on the role of Business Development Manager to support growing US presence MG America appoints Janice Wortham as Regional Sales Manager Wortham will cover the Processing division covering some on the most important pharma stronghold in the US ReViral appoints Alex Sapir as new CEO Sapir will be based at North Carolina’s Research Triangle Park alongside the company’s new CMO, Seth Hetherington Uhlmann Packaging Systems has new US Regional Sales Manager Markus Leuprecht will take over leading the Southwestern US and Texas Lyndra Therapeutics has new CEO Dr Patricia Hurter will begin her new post on 3 September TraceLink appoints four new Board Members New appointments include prominent supply chain industry leaders and former industry analysts; Roddy Martin, John Bermudez, Kevin Young and Steve Collins Ulrich Platte is new CFO of eTheRNA immunotherapies Platte will start at the mRNA immunotherapy company on 3 June Idifarma announces new Director of Operations Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals Immodulon appoints new CSO Effective immediately Thomas Kleen will take on the role within the senior management team Dr William F Feehery is new Certara CEO Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company Prudential family leadership goes to third generation John Clark, son of departing CEO, Dan Clark, and third generation family member, will assume the CEO position

Trending Articles

  1. MasterControl strengthens executive leadership team with two key appointments Wynn Clayton joins as CFO while Ian Ball is promoted to chief sales officer to support the company’s next phase of growth
  2. MHRA scientific leader recognised in 2026 King's Birthday Honours Dr Nicola Rose receives OBE for services to science and public health
  3. Lonza appoints Hans Trees as Global Head of Communications Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
  4. Hansa Biopharma appoints Fredrik Röök as VP Business Development Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
  5. Servomex appoints new Global Sales Director Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all